An interesting example of further diversificationby global food giant Nestle here.
Nestle is rumoured to have paid around £500m (the deal value was not formally disclosed) to acquire Prometheus Laboratories Inc., a maker of treatments for cancer and gastrointestinal illnesses. This is not Nestle first acquisition into consumer healthcare. The Swiss company has said it aims to become the world leader in health-science nutrition in 10 years, extending its dominance beyond coffee, powdered milk and baby food.
Why the change in strategic direction? The answer, simply stated, is growth. Healthcare markets are expected to grow significantly faster than mature food product markets in the medium and long-term. Developing economies are having to handle ageing populations, with consumers increasingly prepared to spend on healthcare and nutrition.
Another reason is profit margins. Net profit margins in pharmaceuticals are generally much higher than those earned in food products, though there is often a long lead time between new product development and product profitability.
FOR MORE REVISION SUPPORT FROM THE TUTOR2U TEAM...
Use the following class codes to join our Zondle revision classes:
Economics: AS Micro 290-66327 AS Macro 290-66328 A2 Micro 290-66329 A2 Macro 290-66330
AQA AS/A2 Business: BUSS1 290-66325 BUSS2 290-66326 BUSS3 290-66323 BUSS4 290-66322
The cameras went behind the scenes at one of tutor2u's exam coaching & revision workshops this summer...
Discover more about our intensive exam coaching & revision workshops desiged to prepare for exams in May & June 2015:
|PowerPoint Lesson Activities||Teacher Conferences & CPD Courses|
|Exam Coaching & Revision Workshops||Pre-release Case Study Toolkits|
|A Level Economics Teaching Support||Resources for Business Studies|